Germany Pemetrexed Market Size & Outlook, 2025-2033


Germany Pemetrexed Market Insights

  • As per Reed Intelligence insights, the Germany Pemetrexed Market stood at USD 168.18 Million in 2024 and is anticipated to grow to USD 194.64 Million by 2033.
  • The Germany market is expected to advance at a CAGR of 1.66% from 2026 through 2033.
  • In 2024, Malignant Pleural Mesothelioma accounted for the highest share of the By Application market size.
  • During the forecast period, Non-Squamous NSCLC is set to register the highest growth, making it the most lucrative By Application segment.

Other Key Findings


  • Germany contributed 7.19% to the global Pemetrexed Market size in 2024.
  • By 2033, United States is forecasted to remain the largest global market for Pemetrexed Market.
  • In Europe, Germany is projected to capture the leading share of market size by 2033.
  • Among Europe markets, Nordic is expected to post the fastest growth, reaching USD 39.9 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 168.18 Million
Market Size In 2033 USD 194.64 Million
Largest segment Malignant Pleural Mesothelioma
Units Revenue in USD Million
CAGR 1.66% (2025-2033)
Segmnetation Covered
By Application
  1. Malignant Pleural Mesothelioma
  2. Non-Squamous NSCLC
By End-User
  1. Hospitals
  2. Oncology Centers
  3. Online Pharmacies
  4. Offline Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends